March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...

Drug-related provisions of a landmark Biden-era law were tied to a decline in cost-related medication nonadherence among ...

On February 5, 2026, President Trump released another namesake initiative, this time aimed at prescription drug prices. The new program, TrumpRx, is advertised as delivering “the world’s lowest prices ...

Medicare Part D changes in 2026 include a $2,100 cap, payment plan rules, prior authorization updates, and new pricing shifts ...

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...

New Medicare reforms under the Inflation Reduction Act aim to lower prescription drug costs by removing the coverage gap, ...

The Protecting Patient Access to Cancer and Complex Therapies Act — PACTA — is critical to NJ patients who need access to ...

President Trump has repeatedly promised to bring down prescription drug prices. His Republican Congress says it shares that goal. But tucked inside the 2026 Consolidated Appropriations Act is a ...

Most Sacramento Medicare enrollees are on track to miss serious new savings in 2026, even as federal rule changes cut drug prices, cap annual pharmacy bills and let people spread big costs across the ...

Expanding insurance promised affordability, but instead it supercharged costs.

Voluntary MFN commitments by 16 manufacturers reportedly cover ~70% of Medicare drug spending, potentially obviating GUARD/GLOBE finalization while avoiding predictable legal challenges. Lindsay ...

As states try to contain the cost of prescription drugs, Virginia lawmakers are pushing an affordability board they believe ...